Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382681096> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4382681096 endingPage "521" @default.
- W4382681096 startingPage "517" @default.
- W4382681096 abstract "Serotonin is a mediator of pulmonary hypoxic vasoconstriction. Experimental studies have shown that serotonin-mediated pulmonary vasoconstriction can be inhibited by cyproheptadine. The aim of this study is to assess whether treatment with cyproheptadine compared to usual care increases ventilatory support-free days during the first 28 days in patients with coronavirus disease 2019 (COVID-19) requiring ventilatory support.This randomized, single-center, open-label clinical trial included patients who were admitted to the intensive care unit (ICU) requiring ventilatory support due to COVID-19. Patients allocated to the intervention group received cyproheptadine for 10 days. The primary outcome was ventilator-free days during the first 28 days.Nineteen patients were randomized to receive cyproheptadine and 21 to the control group. The number of ventilatory support-free days during the first 28 days was not different between the two groups (15.0; 95% CI, 0.0-24.0 days in the control group vs 7.0; 95% CI, 0.0-19.0 days in the intervention group; p = 0.284).In patients with COVID-19 and in need of ventilatory support, the use of cyproheptadine plus usual care, compared with usual care alone, did not increase the number of ventilatory support-free days in 28 days.Boniatti MM, Nedel WL, Rihl MF, Schwarz P, Parolo E, Moretti MMS, et al. Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients with COVID-19: An Open-label, Randomized Clinical Trial. Indian J Crit Care Med 2023;27(7):517-521." @default.
- W4382681096 created "2023-07-01" @default.
- W4382681096 creator A5006681918 @default.
- W4382681096 creator A5025667887 @default.
- W4382681096 creator A5026158213 @default.
- W4382681096 creator A5027232414 @default.
- W4382681096 creator A5027468045 @default.
- W4382681096 creator A5030056121 @default.
- W4382681096 creator A5047812820 @default.
- W4382681096 date "2023-06-30" @default.
- W4382681096 modified "2023-09-30" @default.
- W4382681096 title "Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients with COVID-19: An Open-label, Randomized Clinical Trial" @default.
- W4382681096 cites W2057503806 @default.
- W4382681096 cites W2075824066 @default.
- W4382681096 cites W2091828873 @default.
- W4382681096 cites W2417053559 @default.
- W4382681096 cites W3031152601 @default.
- W4382681096 cites W3033997257 @default.
- W4382681096 cites W3036681929 @default.
- W4382681096 cites W3042442225 @default.
- W4382681096 cites W3044699718 @default.
- W4382681096 cites W3045096104 @default.
- W4382681096 cites W3085046828 @default.
- W4382681096 cites W3102920585 @default.
- W4382681096 cites W3127565334 @default.
- W4382681096 cites W3133132602 @default.
- W4382681096 cites W3135019541 @default.
- W4382681096 cites W3197617691 @default.
- W4382681096 cites W3208556307 @default.
- W4382681096 cites W3215398075 @default.
- W4382681096 doi "https://doi.org/10.5005/jp-journals-10071-24482" @default.
- W4382681096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37502298" @default.
- W4382681096 hasPublicationYear "2023" @default.
- W4382681096 type Work @default.
- W4382681096 citedByCount "0" @default.
- W4382681096 crossrefType "journal-article" @default.
- W4382681096 hasAuthorship W4382681096A5006681918 @default.
- W4382681096 hasAuthorship W4382681096A5025667887 @default.
- W4382681096 hasAuthorship W4382681096A5026158213 @default.
- W4382681096 hasAuthorship W4382681096A5027232414 @default.
- W4382681096 hasAuthorship W4382681096A5027468045 @default.
- W4382681096 hasAuthorship W4382681096A5030056121 @default.
- W4382681096 hasAuthorship W4382681096A5047812820 @default.
- W4382681096 hasBestOaLocation W43826810961 @default.
- W4382681096 hasConcept C126322002 @default.
- W4382681096 hasConcept C168563851 @default.
- W4382681096 hasConcept C170493617 @default.
- W4382681096 hasConcept C177713679 @default.
- W4382681096 hasConcept C2775864247 @default.
- W4382681096 hasConcept C2776376669 @default.
- W4382681096 hasConcept C2778206117 @default.
- W4382681096 hasConcept C2987404301 @default.
- W4382681096 hasConcept C42219234 @default.
- W4382681096 hasConcept C535046627 @default.
- W4382681096 hasConcept C71924100 @default.
- W4382681096 hasConceptScore W4382681096C126322002 @default.
- W4382681096 hasConceptScore W4382681096C168563851 @default.
- W4382681096 hasConceptScore W4382681096C170493617 @default.
- W4382681096 hasConceptScore W4382681096C177713679 @default.
- W4382681096 hasConceptScore W4382681096C2775864247 @default.
- W4382681096 hasConceptScore W4382681096C2776376669 @default.
- W4382681096 hasConceptScore W4382681096C2778206117 @default.
- W4382681096 hasConceptScore W4382681096C2987404301 @default.
- W4382681096 hasConceptScore W4382681096C42219234 @default.
- W4382681096 hasConceptScore W4382681096C535046627 @default.
- W4382681096 hasConceptScore W4382681096C71924100 @default.
- W4382681096 hasIssue "7" @default.
- W4382681096 hasLocation W43826810961 @default.
- W4382681096 hasLocation W43826810962 @default.
- W4382681096 hasLocation W43826810963 @default.
- W4382681096 hasOpenAccess W4382681096 @default.
- W4382681096 hasPrimaryLocation W43826810961 @default.
- W4382681096 hasRelatedWork W2057630253 @default.
- W4382681096 hasRelatedWork W2107899720 @default.
- W4382681096 hasRelatedWork W2327606279 @default.
- W4382681096 hasRelatedWork W2331454882 @default.
- W4382681096 hasRelatedWork W2474790959 @default.
- W4382681096 hasRelatedWork W3159250744 @default.
- W4382681096 hasRelatedWork W4241062279 @default.
- W4382681096 hasRelatedWork W4256514411 @default.
- W4382681096 hasRelatedWork W4292236216 @default.
- W4382681096 hasRelatedWork W2083697902 @default.
- W4382681096 hasVolume "27" @default.
- W4382681096 isParatext "false" @default.
- W4382681096 isRetracted "false" @default.
- W4382681096 workType "article" @default.